A study of programmed death‐1/programmed death ligand and iodine‐induced autoimmune thyroiditis in NOD.H‐2h4 mice
Environmental Toxicology · 2023
DOI: 10.1002/tox.23893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2023. Verfasst von Fan Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, People's Republic of China. Hauptthemen laut MEDLINE: Thyroiditis, Autoimmune, Iodine, B7-H1 Antigen, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: HMU Marshal Initiative Funding, Heilongjiang Postdoctoral Research Startup Funding.
Abstract (Originalsprache)
Excess iodine will trigger the occurrence of autoimmune thyroiditis (AIT), and programmed death‐1 (PD‐1)/programmed death ligand (PD‐L) will also contribute to the development of AIT. The purpose of this study was to explore the role that negative regulatory signals mediated by PD‐1/PD‐L play in the development of spontaneous autoimmune thyroiditis (SAT) in NOD.H‐2h4 mice when they are exposed to iodine. Programmed death ligand 1 (PD‐L1) antibody was administered intraperitoneally to NOD.H‐2h4 mice. The relevant indicators were determined by flow cytometry, real‐time quantitative polymerase chain reaction, enzyme‐linked immunosorbent assay, immunohistochemistry, pathological hematoxylin and eosin staining, and arsenic–cerium catalytic spectrophotometry. Results showed that the level of urinary iodine, the level of thyroid lymphocyte infiltration, the level of thyroglobulin antibodies (TgAb) and interferon (IFN‐γ)/tumor necrosis factor (TNF‐α)/interleukin (IL‐2)/IL‐17, and the relative expression of PD‐1/PD‐L1/programmed death‐2 (PD‐L2) increased with the intervention of excess iodine. After the intervention of the PD‐L1 antibody, the expression of PD‐1/PD‐L1/PD‐L2 in different degrees was inhibited, but the level of thyroid lymphocyte infiltration and serum TgAb/IFN‐γ/TNF‐α/ IL‐2/IL‐17 did not decrease. Collectively, although PD‐1/PD‐L participates in the occurrence of SAT and induces inflammation, administration of the PD‐L1 antibody does not effectively improve the pathological process of SAT. More research is needed to determine whether PD‐1/PD‐L intervention can treat autoimmune thyroid disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, People's Republic of China.
- National Health Commission & Education Bureau of Heilongjiang Province, Key Laboratory of Etiology and Epidemiology, Harbin Medical University, Harbin, People's Republic of China.
- Heilongjiang Provincial Key Laboratory of Trace Elements and Human Health, Harbin Medical University, Harbin, People's Republic of China.
- Control Infection Department, Xi'an First Hospital, Xi'an, People's Republic of China.
ORCID-Profile: Lixiang Liu
Förderung
- HMU Marshal Initiative Funding
- Heilongjiang Postdoctoral Research Startup Funding
Zitieren
APA
Li, F., Zhou, Z., Wang, L., Li, B., Jin, M., Liu, J., Chen, Y., He, Y., Ren, B., Shen, H., & Liu, L. (2023). A study of programmed death‐1/programmed death ligand and iodine‐induced autoimmune thyroiditis in NOD.H‐2h4 mice. Environmental Toxicology. https://doi.org/10.1002/tox.23893
Vancouver
Li F, Zhou Z, Wang L, Li B, Jin M, Liu J, et al. A study of programmed death‐1/programmed death ligand and iodine‐induced autoimmune thyroiditis in NOD.H‐2h4 mice. Environmental Toxicology. 2023. doi:10.1002/tox.23893
BibTeX
@article{Li2023,
author = {Li, Fan and Zhou, Zheng and Wang, Lingbo and Li, Baoxiang and Jin, Meihui and Liu, Jinjin and Chen, Yun and He, Yanhong and Ren, Bingxuan and Shen, Hongmei and Liu, Lixiang},
title = {A study of programmed death‐1/programmed death ligand and iodine‐induced autoimmune thyroiditis in NOD.H‐2h4 mice},
journal = {Environmental Toxicology},
year = {2023},
doi = {10.1002/tox.23893}
}
EUVIMED